Navigation Links
Velocity Pharmaceutical Development and Remeditex Ventures Announce Collaboration Agreement and Initial Co-Investment
Date:8/19/2013

SOUTH SAN FRANCISCO, Calif. and DALLAS, Aug. 19, 2013 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD") and Remeditex Ventures, LLC ("Remeditex") announced today the signing of a collaboration agreement.  Under this agreement, VPD and Remeditex will jointly evaluate pharmaceutical development opportunities for management by the VPD development team and potential funding from Velocity Pharmaceutical Holdings, LLC and Remeditex.   

In conjunction with this collaboration, both VPD and Remeditex have announced an investment by Remeditex in a VPD-managed pharmaceutical development company, Tigercat Pharma, Inc.

"VPD has assembled a world-class group of scientists and drug developers" said Dennis Stone, Chief Scientific Officer of Remeditex.  "Everyone at Remeditex is thrilled to be working with the VPD team.  We look forward to identifying and developing a series of promising pharmaceutical candidates in partnership with VPD."

"It is a great honor for us to join in this partnership with Remeditex" said David Collier, CEO of VPD.  "The Remeditex team, network and experience perfectly complement the skill set we have at VPD.  Having Remeditex as a potential funding partner greatly expands the scope of opportunities we can address at VPD."

About Velocity Pharmaceutical Development, LLC
VPD is a pharmaceutical development organization dedicated to rapidly advancing promising drug candidates to clinical proof of concept using a highly virtual management model.  VPD seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated.  VPD then manages a highly virtual development program for each drug candidate intended to generate convincing human proof of concept data (g
'/>"/>

SOURCE Velocity Pharmaceutical Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Asterias Biotherapeutics Inc. (OTCBB: ASTY) has received ... to initiate a Phase 1/2a clinical trial of its ... injury.  The approved trial follows the successful completion of ... is designed to assess safety and activity of escalating ... cord injuries, the first targeted indication for AST-OPC1 and ...
(Date:8/26/2014)... STATESVILLE, N.C., Aug. 26, 2014  Kewaunee Scientific Corporation ... its first quarter ended July 31, 2014. ... sales of $32,003,000 in the first quarter last year. ... per diluted share, as compared to net earnings of ... quarter of the prior year. However, both sales and ...
(Date:8/26/2014)... 26, 2014 Research and Markets ... Meter Industry Report 2014 " report to their ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The glucose meter market analysis is provided for ...
Breaking Medicine Technology:Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 2Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 3Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 4Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury 5Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Global Glucose Meter Industry Report 2014 2Global Glucose Meter Industry Report 2014 3
(Date:8/27/2014)... Casey Diekman, assistant professor of mathematical sciences ... to gain greater insight into the biological clock that ... harmonized the behavior of humans and all other mammals ... of light and dark experienced each day and with ... related to natural patterns of sleep/wake behavior which, when ...
(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... The use of ESAs to treat ... may eliminate the need for blood transfusion and associated ... webinar, Dr. Zanhua Yi, board certified in hematology, oncology, ... necessity of erythropoiesis-stimulating agents (ESAs) in the treatment of ... Food and Drug Administration (FDA) has approved three ESAs ...
(Date:8/27/2014)... Michael A. Bottar has been ... Best Lawyers In America© for the practice areas of ... - Plaintiffs." , Bottar received his undergraduate degree from ... of Syracuse University College of Law where is an ... of the Syracuse Law Review Survey of New York ...
Breaking Medicine News(10 mins):Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 2Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 3Health News:NJIT Researcher Receives New NSF Funding to Study Fundamental Rhythms of Life 4Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3Health News:Michael A. Bottar Selected For Inclusion In The Best Lawyers In America© 2015 2
... 25 - "We are excited about,the strong efforts in ... facility," said Judie Brown, president of American Life,League., ... nation,with 287 surgical and medical abortion facilities across the ... abortion operation in the,Denver suburb of Stapleton and local ...
... stem cells that differentiate into bone appears to cause regeneration ... strategy for osteoporosis, according to a report in the February ... by researchers from Massachusetts General Hospital (MGH) and the Harvard ... medication used to treat bone marrow cancer improved bone density ...
... while eating out in the New Year, SAN ... the New Year,s resolution list. But for the thousands ... is not always,easy. Today, American Express issued its Tastemaker ... best San Francisco restaurants where diners,can get a fresh, ...
... 25 3.5 million lives could be,saved over the ... and treatment measures in the 30 hardest hit countries ... the World Economic,Forum. Additionally, rapid scale-up would increase annual ... prevent 672 million malaria cases, and,free up 427,000 needed ...
... of teenagers may have metabolic syndrome, a clustering of risk ... and diabetes in adulthood. This shocking statistic represents some of ... in children and adolescents a necessary starting point for ... in youth than it has been in adults. , With ...
... Full Year 2007 Revenue of Approximately $154 million, Announces Full ... ... SAN DIEGO, Jan. 25 NuVasive, Inc. (Nasdaq:,NUVA), a medical ... for the spine, today announced,preliminary unaudited financial results for the ...
Cached Medicine News:Health News:Turning on adult stem cells may help repair bone 2Health News:Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite 2Health News:Eating Healthy in the New Year? American Express Tastemakers Dish on the Top San Francisco Restaurants for Grabbing a Healthy Bite 3Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 2Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 3Health News:Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds 4Health News:Metabolic syndrome affects nearly 1 in 10 US teens 2Health News:Metabolic syndrome affects nearly 1 in 10 US teens 3Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 2Health News:NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results 3
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
... SofLens66 Toric lens are fit ... current soft toric lens wearers who ... with the health and convenience of ... want the convenience of contact lenses; ...
The Heine C series binocular loupes offer extremely low weight (46g), crisp views, and quality German construction in an affordable instrument....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
Medicine Products: